|
|
|
|
| LEADER |
01832nam a2200301 i 4500 |
| 001 |
27452 |
| 003 |
BD-DhAAL |
| 005 |
20130902112329.0 |
| 008 |
120208s2012 enka b 001 0 eng |
| 010 |
|
|
|a 2012932747
|
| 020 |
|
|
|a 9780199577170 (pbk. : acidfree paper)
|
| 040 |
|
|
|a DLC
|b eng
|c DLC
|e rda
|d DLC
|d BD-DhAAL
|
| 050 |
0 |
0 |
|a RC268.4
|b .P425 2012
|
| 082 |
0 |
0 |
|a 616.99/4
|2 23
|
| 100 |
1 |
|
|a Pecorino, Lauren.
|9 2880
|
| 245 |
1 |
0 |
|a Molecular biology of cancer :
|b mechanisms, targets, and therapeutics /
|c Lauren Pecorino
|
| 250 |
|
|
|a Third edition.
|
| 260 |
|
|
|a Oxford :
|b Oxford University Press,
|c 2012
|
| 300 |
|
|
|a xviii, 342 pages :
|b illustrations (some color) ;
|c 25 cm.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a DNA structure and stability : mutations versus repair -- Regulation of gene expression -- Growth factor signaling and oncogenes -- The cell cycle -- Growth inhibition and tumor suppressor genes -- Apoptosis -- Stem cells and differentiation -- Metastasis -- The immune system, infections, and inflammation -- Nutrients, hormones, and gene interactions -- The cancer industry : drug development, pharmocogenomics, and clinical trial design -- Cancer in the future : focus on cancer vaccines and technology.
|
| 541 |
|
|
|e 27452, 27453
|
| 650 |
|
0 |
|a Cancer
|x Molecular aspects.
|9 2881
|
| 650 |
|
0 |
|a Cancer cells.
|9 2882
|
| 942 |
|
|
|2 ddc
|c BK
|
| 999 |
|
|
|c 13916
|d 13916
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 616_994000000000000_PEC
|7 0
|9 23288
|a BRACUL
|b BRACUL
|c GEN
|d 2013-09-02
|e Karim International
|g 4300.00
|l 15
|m 104
|o 616.994 PEC
|p 3010027452
|q 2025-03-05
|r 2025-02-17
|s 2025-02-17
|t 1
|w 2013-09-02
|y BK
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 616_994000000000000_PEC
|7 0
|9 23289
|a BRACUL
|b BRACUL
|c GEN
|d 2013-09-02
|e Karim International
|g 4300.00
|l 7
|m 94
|o 616.994 PEC
|p 3010027453
|q 2025-02-27
|r 2024-10-22
|s 2024-10-22
|t 2
|w 2013-09-02
|y BK
|